The University of Oklahoma College of Medicine has announced the appointment of T.R. Lewis, M.D., as associate dean for student affairs, effective Jan. 25, 2026, pending approval by the OU Board of Regents.

The University of Oklahoma College of Medicine has named Kelly Stratton, M.D., FACS, as associate dean for veterans affairs, pending approval by the OU Board of Regents.

A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.

U.S. Poison Centers save $3.1 billion every year in medical costs and lost productivity, according to a new independent study released by America’s Poison Centers®. Conducted by RAND, the report confirms that U.S. Poison Centers provide substantial economic and societal benefits for communities across the country. In 2025, the Oklahoma Poison Center managed 31,462 human exposure cases and handled a total of 36,167 incoming calls, including 4,580 informational calls. To ensure patient safety and continuity of care, specialists conducted 34,335 follow-up calls, resulting in more than 70,500 total calls answered and placed in support of Oklahoma families and health care providers.

Abdul Rafeh Naqash, M.D., associate professor of medicine at the University of Oklahoma College of Medicine and senior associate director of AI and Data Science at OU Health Stephenson Cancer Center, has been awarded the 2026 Young Physician-Scientist Award from the American Society for Clinical Investigation (ASCI).